BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30953192)

  • 1. Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model.
    Miyake K; Murata T; Murakami T; Zhao M; Kiyuna T; Kawaguchi K; Igarashi K; Miyake M; Lwin TM; Hozumi C; Komatsu S; Kikuchi T; Bouvet M; Shimoya K; Singh SR; Endo I; Hoffman RM
    Arch Gynecol Obstet; 2019 Jun; 299(6):1683-1690. PubMed ID: 30953192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models.
    Kawaguchi K; Miyake K; Zhao M; Kiyuna T; Igarashi K; Miyake M; Higuchi T; Oshiro H; Bouvet M; Unno M; Hoffman RM
    Cell Cycle; 2018; 17(16):2019-2026. PubMed ID: 29963961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeting Salmonella typhimurium A1-R overcomes partial carboplatinum-resistance of a cancer of unknown primary (CUP).
    Miyake K; Kiyuna T; Miyake M; Zhao M; Wangsiricharoen S; Kawaguchi K; Zhang Z; Higuchi T; Razmjooei S; Li Y; Nelson SD; Russell T; Singh A; Murakami T; Hiroshima Y; Momiyama M; Matsuyama R; Chishima T; Singh SR; Chawla SP; Eilber FC; Endo I; Hoffman RM
    Tissue Cell; 2018 Oct; 54():144-149. PubMed ID: 30309504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.
    Murakami T; Murata T; Kawaguchi K; Kiyuna T; Igarashi K; Hwang HK; Hiroshima Y; Hozumi C; Komatsu S; Kikuchi T; Lwin TM; Delong JC; Miyake K; Zhang Y; Tanaka K; Bouvet M; Endo I; Hoffman RM
    Anticancer Res; 2017 Jan; 37(1):61-65. PubMed ID: 28011474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model.
    Kawaguchi K; Igarashi K; Murakami T; Chmielowski B; Kiyuna T; Zhao M; Zhang Y; Singh A; Unno M; Nelson SD; Russell TA; Dry SM; Li Y; Eilber FC; Hoffman RM
    Oncotarget; 2016 Dec; 7(52):85929-85936. PubMed ID: 27835903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing's Sarcoma in a Patient-Derived Orthotopic Xenograft Model.
    Miyake K; Kiyuna T; Li S; Han Q; Tan Y; Zhao M; Oshiro H; Kawaguchi K; Higuchi T; Zhang Z; Razmjooei S; Barangi M; Wangsiricharoen S; Murakami T; Singh AS; Li Y; Nelson SD; Eilber FC; Bouvet M; Hiroshima Y; Chishima T; Matsuyama R; Singh SR; Endo I; Hoffman RM
    Chemotherapy; 2018; 63(5):278-283. PubMed ID: 30673664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.
    Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Li S; Han Q; Tan Y; Zhao M; Li Y; Nelson SD; Dry SM; Singh AS; Elliott IA; Russell TA; Eckardt MA; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
    Cell Cycle; 2018; 17(6):801-809. PubMed ID: 29374999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.
    Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Zhao M; Zhang Y; Nelson SD; Russell TA; Dry SM; Singh AS; Chmielowski B; Li Y; Unno M; Eilber FC; Hoffman RM
    Cell Cycle; 2017 Jul; 16(13):1288-1294. PubMed ID: 28622068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model.
    Murakami T; DeLong J; Eilber FC; Zhao M; Zhang Y; Zhang N; Singh A; Russell T; Deng S; Reynoso J; Quan C; Hiroshima Y; Matsuyama R; Chishima T; Tanaka K; Bouvet M; Chawla S; Endo I; Hoffman RM
    Oncotarget; 2016 Mar; 7(11):12783-90. PubMed ID: 26859573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Methioninase Combined With Tumor-targeting
    Igarashi K; Kawaguchi K; Zhao M; Han Q; Tan Y; Kiyuna T; Miyake K; Higuchi T; Nelson SD; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Singh SR; Tsuchiya H; Hoffman RM
    Anticancer Res; 2020 May; 40(5):2515-2523. PubMed ID: 32366396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial administration of tumor-targeting Salmonella typhimurium A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.
    Igarashi K; Kawaguchi K; Murakami T; Kiyuna T; Miyake K; Nelson SD; Dry SM; Li Y; Yanagawa J; Russell TA; Singh AS; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
    Cell Cycle; 2017 Jun; 16(12):1164-1170. PubMed ID: 28494180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
    Higuchi T; Kawaguchi K; Miyake K; Oshiro H; Zhang Z; Razmjooei S; Wangsiricharoen S; Igarashi K; Yamamoto N; Hayashi K; Kimura H; Miwa S; Nelson SD; Dry SM; Li Y; Chawla SP; Eilber FC; Singh SR; Tsuchiya H; Hoffman RM
    Biomed Pharmacother; 2019 Mar; 111():835-840. PubMed ID: 30616082
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Hamada K; Aoki Y; Yamamoto J; Hozumi C; Zhao M; Murata T; Sugisawa N; Bouvet M; Tsunoda T; Hoffman RM
    In Vivo; 2021; 35(6):3067-3071. PubMed ID: 34697138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model.
    Kiyuna T; Murakami T; Tome Y; Kawaguchi K; Igarashi K; Zhang Y; Zhao M; Li Y; Bouvet M; Kanaya F; Singh A; Dry S; Eilber FC; Hoffman RM
    Oncotarget; 2016 May; 7(22):33046-54. PubMed ID: 27105519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcoma.
    Kiyuna T; Tome Y; Murakami T; Zhao M; Miyake K; Igarashi K; Kawaguchi K; Miyake M; Oshiro H; Higuchi T; Li Y; Dry SM; Nelson SD; Russell TA; Eckardt MA; Singh AS; Kanaya F; Eilber FC; Hoffman RM
    J Cell Biochem; 2018 Sep; 119(9):7827-7833. PubMed ID: 29932244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral recombinant methioninase combined with paclitaxel arrests recalcitrant ovarian clear cell carcinoma growth in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
    Sugisawa N; Higuchi T; Han Q; Hozumi C; Yamamoto J; Tashiro Y; Nishino H; Kawaguchi K; Bouvet M; Murata T; Unno M; Hoffman RM
    Cancer Chemother Pharmacol; 2021 Jul; 88(1):61-67. PubMed ID: 33768300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models.
    Hiroshima Y; Zhang Y; Zhao M; Zhang N; Murakami T; Maawy A; Mii S; Uehara F; Yamamoto M; Miwa S; Yano S; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Hoffman RM
    PLoS One; 2015; 10(6):e0120358. PubMed ID: 26047477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX).
    Hiroshima Y; Zhao M; Maawy A; Zhang Y; Katz MH; Fleming JB; Uehara F; Miwa S; Yano S; Momiyama M; Suetsugu A; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Cell Biochem; 2014 Jul; 115(7):1254-61. PubMed ID: 24435915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago.
    Murakami T; Kiyuna T; Kawaguchi K; Igarashi K; Singh AS; Hiroshima Y; Zhang Y; Zhao M; Miyake K; Nelson SD; Dry SM; Li Y; DeLong JC; Lwin TM; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
    Cell Cycle; 2017 Jun; 16(11):1046-1052. PubMed ID: 28296559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
    Kawaguchi K; Igarashi K; Murakami T; Zhao M; Zhang Y; Chmielowski B; Kiyuna T; Nelson SD; Russell TA; Dry SM; Li Y; Unno M; Eilber FC; Hoffman RM
    J Cell Biochem; 2017 Aug; 118(8):2314-2319. PubMed ID: 28106277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.